Showing results (1-10 of 24) with videos related to
Sort By:
Pageof 3
Methods in Molecular Biology (Clifton, N.J.)|August 10, 2024
Purification of Epizootic Hemorrhagic Disease Virus (and Other Orbiviruses) Particles from Infected Mammalian or Insect CellsMarc Guimerà Busquets, Karin E DarpelTransboundary and Emerging Diseases|November 22, 2020
Depletion of CD8+ T cells from vaccinated goats does not affect protection from challenge with wild-type peste des petits ruminants virusMichael D Baron, Sophia Hodgson, Katy Moffat, et al.Biological Procedures Online|November 6, 2023
Visualisation of Bluetongue Virus in the Salivary Apparatus of Culicoides Biting Midges Highlights the Accessory Glands as a Primary Arboviral Infection SiteMarc Guimerà Busquets, Faye V Brown, Simon T Carpenter, et al.The Journal of General Virology|March 8, 2019
A low-passage insect-cell isolate of bluetongue virus uses a macropinocytosis-like entry pathway to infect natural target cells derived from the bovine hostLisa M Stevens, Katy Moffat, Lyndsay Cooke, et al.Journal of Virology|September 28, 2018
Comparison of the Immunogenicities and Cross-Lineage Efficacies of Live Attenuated Peste des Petits Ruminants Virus Vaccines PPRV/Nigeria/75/1 and PPRV/Sungri/96Sophia Hodgson, Katy Moffat, Holly Hill, et al.Plos One|August 14, 2013
Measurement of the infection and dissemination of bluetongue virus in culicoides biting midges using a semi-quantitative rt-PCR assay and isolation of infectious virusEva Veronesi, Frank Antony, Simon Gubbins, et al.Viruses|June 2, 2021
An Early Block in the Replication of the Atypical Bluetongue Virus Serotype 26 in Culicoides Cells Is Determined by Its Capsid ProteinsMarc Guimerà Busquets, Gillian D Pullinger, Karin E Darpel, et al.Vaccine|November 10, 2009
Viraemia and clinical disease in Dorset Poll sheep following vaccination with live attenuated bluetongue virus vaccines serotypes 16 and 4Eva Veronesi, Karin E Darpel, Chris Hamblin, et al.Plos One|March 23, 2011
Saliva proteins of vector Culicoides modify structure and infectivity of bluetongue virus particlesKarin E Darpel, Kathrin F A Langner, Manfred Nimtz, et al.NPJ Vaccines|June 3, 2024
Long-term trial of protection provided by adenovirus-vectored vaccine expressing the PPRV H proteinKarin E Darpel, Amanda Corla, Anna Stedman, et al.Pageof 3